224 related articles for article (PubMed ID: 11156236)
1. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance.
Kase S; Sugio K; Yamazaki K; Okamoto T; Yano T; Sugimachi K
Clin Cancer Res; 2000 Dec; 6(12):4789-96. PubMed ID: 11156236
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma.
Ikeguchi M; Makino M; Kaibara N
J Surg Oncol; 2001 Jul; 77(3):201-7. PubMed ID: 11455558
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH
Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683
[TBL] [Abstract][Full Text] [Related]
5. The reduced expression of e-cadherin, alpha-catenin and gamma-catenin but not beta-catenin in human lung cancer.
Toyoyama H; Nuruki K; Ogawa H; Yanagi M; Matsumoto H; Nishijima H; Shimotakahara T; Aikou T; Ozawa M
Oncol Rep; 1999; 6(1):81-5. PubMed ID: 9864406
[TBL] [Abstract][Full Text] [Related]
6. The significance of E-cadherin and alpha-, beta-, and gamma-catenin expression in surgically treated non-small cell lung cancers of 3 cm or less in size.
Lee YC; Wu CT; Chen CS; Hsu HH; Chang YL
J Thorac Cardiovasc Surg; 2002 Mar; 123(3):502-7. PubMed ID: 11882822
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer.
Kimura K; Endo Y; Yonemura Y; Heizmann CW; Schafer BW; Watanabe Y; Sasaki T
Int J Oncol; 2000 Jun; 16(6):1125-31. PubMed ID: 10811984
[TBL] [Abstract][Full Text] [Related]
8. Micrometastasis in the bone marrow of patients with lung cancer associated with a reduced expression of E-cadherin and beta-catenin: risk assessment by immunohistochemistry.
Sugio K; Kase S; Sakada T; Yamazaki K; Yamaguchi M; Ondo K; Yano T
Surgery; 2002 Jan; 131(1 Suppl):S226-31. PubMed ID: 11821816
[TBL] [Abstract][Full Text] [Related]
9. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin-beta-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis.
Salon C; Moro D; Lantuejoul S; Brichon Py Py; Drabkin H; Brambilla C; Brambilla E
Hum Pathol; 2004 Sep; 35(9):1148-55. PubMed ID: 15343518
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
12. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis.
Zheng Z; Pan J; Chu B; Wong YC; Cheung AL; Tsao SW
Hum Pathol; 1999 Apr; 30(4):458-66. PubMed ID: 10208469
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions.
Nakanishi Y; Ochiai A; Akimoto S; Kato H; Watanabe H; Tachimori Y; Yamamoto S; Hirohashi S
Oncology; 1997; 54(2):158-65. PubMed ID: 9075789
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma.
Chow V; Yuen AP; Lam KY; Tsao GS; Ho WK; Wei WI
J Cancer Res Clin Oncol; 2001 Jan; 127(1):59-63. PubMed ID: 11206273
[TBL] [Abstract][Full Text] [Related]
15. Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas.
Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Ferreira VM; Lopes CS
Hum Pathol; 2004 Jun; 35(6):663-9. PubMed ID: 15188131
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma.
Nozawa N; Hashimoto S; Nakashima Y; Matsuo Y; Koga T; Sugio K; Niho Y; Harada M; Sueishi K
Pathol Res Pract; 2006; 202(9):639-50. PubMed ID: 16843618
[TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma.
Lin YC; Wu MY; Li DR; Wu XY; Zheng RM
World J Gastroenterol; 2004 Nov; 10(22):3235-9. PubMed ID: 15484291
[TBL] [Abstract][Full Text] [Related]
20. Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis.
Zhao XJ; Li H; Chen H; Liu YX; Zhang LH; Liu SX; Feng QL
World J Gastroenterol; 2003 Feb; 9(2):225-32. PubMed ID: 12532436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
